Can neuropathic screening tools be used as outcome measures?

Area of Science:

• Pain research
• Psychometrics
• Clinical measurement

Background:

• Neuropathic pain screening tools are crucial for clinical studies.
• The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) is a commonly used screening tool.
• Evaluating the psychometric properties of screening tools is essential for their valid application.

Purpose of the Study:

• To assess if the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) meets Rasch model criteria for interval-level measurement.
• To determine the suitability of the LANSS as an outcome measure in clinical trials for neuropathic pain.

Main Methods:

• Rasch analysis was performed on LANSS data from 2,480 chronic pain patients.
• Data included specific diagnostic groups: diabetic neuropathy, postsurgical pain, osteoarthritis, posttraumatic injury, and low back pain.
• Key assessments included Rasch model fit, reliability, dimensionality, and differential item functioning.

Main Results:

• The LANSS demonstrated acceptable Rasch model fit in diabetic neuropathy and chronic postsurgical pain groups only.
• These specific groups showed unidimensionality and no differential item functioning by age or gender.
• Overall scale reliability supports group-level analysis, not individual patient assessment.

Conclusions:

• The LANSS can serve as an outcome measure in clinical studies for specific neuropathic pain populations.
• However, its reliability is insufficient for individual-level assessment across diverse pain diagnoses.
• The LANSS is best utilized as a diagnostic instrument rather than a generalized measurement scale.